Tiếp theo

Tự chạy

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Lượt xem • 07/14/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy